Park Ha Biological Technology (BYAH) Other Accumulated Expenses (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Other Accumulated Expenses for 3 consecutive years, with $167185.0 the latest figure, recorded in Q2 2026.

• Quarterly Other Accumulated Expenses rose 2141.09% year-over-year to $167185.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $167185.0 (up 2141.09% YoY) and the FY2025 annual result came in at $76226.0, changed N/A from the prior year.
• Other Accumulated Expenses grew to $167185.0 in Q2 2026 per BYAH's latest filing, from $76226.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for BYAH reached as high as $167185.0 in Q2 2026 and fell as low as $7460.0 in Q2 2025.
• A 3-year average of $79758.0 and a median of $72193.5 in 2023 frame the typical range for Other Accumulated Expenses.
• The largest YoY upside for Other Accumulated Expenses was 2141.09% in 2026 against a maximum downside of 2141.09% in 2026.
• Year by year, Other Accumulated Expenses stood at $68161.0 in 2023, then gained by 11.83% to $76226.0 in 2025, then jumped by 119.33% to $167185.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $167185.0, $76226.0, and $7460.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.